175 related articles for article (PubMed ID: 11782253)
1. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.
Locher CP; Witt SA; Herndier BG; Tenner-Racz K; Racz P; Levy JA
Immunol Rev; 2001 Oct; 183():127-40. PubMed ID: 11782253
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans.
Locher CP; Barnett SW; Herndier BG; Blackbourn DJ; Reyes-Terán G; Murthy KK; Brasky KM; Hubbard GB; Reinhart TA; Haase AT; Levy JA
Arch Pathol Lab Med; 1998 Jun; 122(6):523-33. PubMed ID: 9625420
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons.
Locher CP; Blackbourn DJ; Levy JA
Immunol Lett; 1999 Mar; 66(1-3):151-7. PubMed ID: 10203048
[TBL] [Abstract][Full Text] [Related]
4. Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.
Locher CP; Witt SA; Herndier BG; Abbey NW; Tenner-Racz K; Racz P; Kiviat NB; Murthy KK; Brasky K; Leland M; Levy JA
J Virol; 2003 Jan; 77(1):77-83. PubMed ID: 12477812
[TBL] [Abstract][Full Text] [Related]
5. Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons.
Locher CP; Blackbourn DJ; Herndier BG; Reyes-Terán G; Barnett SW; Murthy KK; Levy JA
AIDS Res Hum Retroviruses; 1998 Jan; 14(1):79-82. PubMed ID: 9453254
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.
Locher CP; Witt SA; Ashlock BM; Polacino P; Hu SL; Shiboski S; Schmidt AM; Agy MB; Anderson DM; Staprans SI; zur Megede J; Levy JA
Vaccine; 2004 Jun; 22(17-18):2261-72. PubMed ID: 15149785
[TBL] [Abstract][Full Text] [Related]
7. An AIDS-like condition induced in baboons by HIV-2.
Barnett SW; Murthy KK; Herndier BG; Levy JA
Science; 1994 Oct; 266(5185):642-6. PubMed ID: 7939718
[TBL] [Abstract][Full Text] [Related]
8. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
Klinger JM; Himathongkham S; Legg H; Luciw PA; Barnett SW
AIDS; 1998 May; 12(8):849-57. PubMed ID: 9631137
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in baboons vaccinated with HIV-2 genetic expression libraries.
Locher CP; Sykes KF; Blackbourn DJ; Johnston SA
J Med Primatol; 2002 Dec; 31(6):323-9. PubMed ID: 12519210
[TBL] [Abstract][Full Text] [Related]
10. Infection of baboons with simian/human immunodeficiency viruses.
Allan JS; Ray P; Broussard S; Whitehead E; Hubbard G; Butler T; Brasky K; Luciw P; Cheng-Mayer C; Levy JA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):429-41. PubMed ID: 7627620
[TBL] [Abstract][Full Text] [Related]
11. Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.
Locher CP; Blackbourn DJ; Barnett SW; Murthy KK; Cobb EK; Rouse S; Greco G; Reyes-Terán G; Brasky KM; Carey KD; Levy JA
J Infect Dis; 1997 Oct; 176(4):948-59. PubMed ID: 9333153
[TBL] [Abstract][Full Text] [Related]
12. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
13. CD8+ cells from HIV-2-infected baboons control HIV replication.
Blackbourn DJ; Locher CP; Ramachandran B; Barnett SW; Murthy KK; Carey KD; Brasky KM; Levy JA
AIDS; 1997 May; 11(6):737-46. PubMed ID: 9143605
[TBL] [Abstract][Full Text] [Related]
14. Use of Old World monkeys for acquired immunodeficiency syndrome research.
Nicol I; Messinger D; Dubouch P; Bernard J; Desportes I; Jouffre R; Snart R; Nara P; Gallo RC; Zagury D
J Med Primatol; 1989; 18(3-4):227-36. PubMed ID: 2760915
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons.
Locher CP; Fujimura S; Murthy KK; Brasky K; Leland M; Levy JA
AIDS Res Hum Retroviruses; 2003 Jan; 19(1):31-40. PubMed ID: 12581514
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2.
Barnett SW; Legg HS; Sun Y; Klinger J; Blackbourn DJ; Locher CP; Levy JA
Virology; 1996 Aug; 222(1):257-61. PubMed ID: 8806506
[TBL] [Abstract][Full Text] [Related]
17. Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques.
Kent SJ; Ada GL; Hayes E; Lewis IM
Immunol Rev; 2001 Oct; 183():94-108. PubMed ID: 11782250
[TBL] [Abstract][Full Text] [Related]
18. Simian T Lymphotropic Virus 1 Infection of Papio anubis:
Termini JM; Magnani DM; Maxwell HS; Lauer W; Castro I; Pecotte J; Barber GN; Watkins DI; Desrosiers RC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28724769
[TBL] [Abstract][Full Text] [Related]
19. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Impact of CD8
Rife Magalis B; Nolan DJ; Autissier P; Burdo TH; Williams KC; Salemi M
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
